{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "11315120", "DateCompleted": {"Year": "2001", "Month": "09", "Day": "13"}, "DateRevised": {"Year": "2017", "Month": "05", "Day": "11"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0001-5385", "JournalIssue": {"Volume": "56", "Issue": "1", "PubDate": {"Year": "2001", "Month": "Feb"}}, "Title": "Acta cardiologica", "ISOAbbreviation": "Acta Cardiol"}, "ArticleTitle": "Treatment at discharge after myocardial infarction in 2,102 patients. The PRIMA study. Prise en charge de l'Infarctus du Myocarde Aigu.", "Pagination": {"StartPage": "17", "EndPage": "26", "MedlinePgn": "17-26"}, "Abstract": {"AbstractText": ["This study sought to examine the use of treatments at discharge in patients hospitalized for myocardial infarction in a French region.", "Data from 2,102 patients discharged after myocardial infarction were prospectively collected at 48 university, community, and private hospitals in three departments in the Rh ne-Alpes region between September 1, 1993 and January 31, 1995. Beta-blockers were prescribed in 59% of the patients, calcium channel blockers in 22%, nitrates in 59%, antiplatelet agents in 82%, anticoagulants in 26%, angiotensin-converting enzyme inhibitors in 36%, diuretics in 33%. Beta-blockers were prescribed less often in older patients, and in patients with higher Killip classes or a history of pulmonary disease. Calcium channel blockers were prescribed more often in older patients, and in patients with a history of diabetes, pulmonary disease, or non-Q wave myocardial infarction. Nitrates were prescribed more often in older patients. Angiotensin-converting enzyme inhibitors were prescribed more often in patients with a history of diabetes, hypertension, or anterior myocardial infarction, and less often in patients with a history of renal failure. Diuretics were prescribed more often in older patients, and in patients with a history of renal failure, diabetes, hypertension, or higher Killip classes.", "There is still underuse of beneficial treatments, particularly in elderly patients."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "H pital Cardiovasculaire et Pneumologique Louis Pradel, Lyon, France."}], "Identifier": [], "LastName": "Excoffier", "ForeName": "S", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "De Gevigney", "ForeName": "G", "Initials": "G"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ecochard", "ForeName": "R", "Initials": "R"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Rabilloud", "ForeName": "M", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Cao", "ForeName": "D", "Initials": "D"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Cheneau", "ForeName": "E", "Initials": "E"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Milon", "ForeName": "H", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Delahaye", "ForeName": "F", "Initials": "F"}], "PublicationTypeList": ["Journal Article", "Multicenter Study", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Acta Cardiol", "NlmUniqueID": "0370570", "ISSNLinking": "0001-5385"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Adrenergic beta-Antagonists"}, {"RegistryNumber": "0", "NameOfSubstance": "Angiotensin-Converting Enzyme Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Anti-Arrhythmia Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Anticoagulants"}, {"RegistryNumber": "0", "NameOfSubstance": "Calcium Channel Blockers"}, {"RegistryNumber": "0", "NameOfSubstance": "Diuretics"}, {"RegistryNumber": "0", "NameOfSubstance": "Nitrates"}, {"RegistryNumber": "0", "NameOfSubstance": "Platelet Aggregation Inhibitors"}], "MeshHeadingList": [{"QualifierName": ["therapeutic use"], "DescriptorName": "Adrenergic beta-Antagonists"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": [], "DescriptorName": "Analysis of Variance"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Angiotensin-Converting Enzyme Inhibitors"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Anti-Arrhythmia Agents"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Anticoagulants"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Calcium Channel Blockers"}, {"QualifierName": [], "DescriptorName": "Chi-Square Distribution"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Digitalis"}, {"QualifierName": [], "DescriptorName": "Disease Management"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Diuretics"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Logistic Models"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Myocardial Infarction"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Nitrates"}, {"QualifierName": [], "DescriptorName": "Odds Ratio"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Plants, Toxic"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Platelet Aggregation Inhibitors"}, {"QualifierName": [], "DescriptorName": "Prospective Studies"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2001", "Month": "4", "Day": "21", "Hour": "10", "Minute": "0"}, {"Year": "2001", "Month": "9", "Day": "14", "Hour": "10", "Minute": "1"}, {"Year": "2001", "Month": "4", "Day": "21", "Hour": "10", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["11315120", "10.2143/AC.56.1.2005589"]}}], "PubmedBookArticle": []}